Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
About
This Notice of Funding Opportunity (NOFO) aims to support new biomedical, behavioral, and social science investigators who are in the early stages of establishing independent careers in tobacco regulatory research. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of research methodology, and development of new research technology. Applicants are encouraged to conduct projects that ultimately have the potential to inform regulations on tobacco product manufacturing, distribution, and marketing. Research projects must address one or more High-Priority Research Topic(s) related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The awards under this NOFO will be administered by NIH using funds made available through FDA CTP and the FSPTCA. Research results from this NOFO are expected to generate findings and data directly relevant to informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
The Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) is a federal funding opportunity designed to support early-career researchers and new investigators establishing independent careers in tobacco regulatory science. Administered by the National Institutes of Health (NIH) using funds from the FDA Center for Tobacco Products (CTP), this program supports biomedical, behavioral, and social science research with direct applicability to tobacco product regulation. The R03 mechanism funds diverse project types including pilot and feasibility studies, secondary data analysis, self-contained research projects, research methodology development, and new research technology development. Funded research must address high-priority topics relevant to FDA's regulatory authority over tobacco manufacturing, distribution, and marketing as established by the Family Smoking Prevention and Tobacco Control Act (FSPTCA). This grant is ideal for new investigators seeking to establish their research portfolio in tobacco regulatory science while contributing to evidence-based public health protection. The program prioritizes research that generates findings directly informing FDA tobacco product regulations and protecting public health through rigorous, innovative science.
Funding Facts
● Applications openDeadline
July 14, 2026
Award Amount
Up to $75K
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
Up to $75K
Deadline
2026-07-14
Grant Type
federal
Application Cycle
Annual (Next deadline: July 14, 2026)
Best For
New investigators and early-career researchers in biomedical, behavioral, and social sciences establishing independent careers in tobacco regulatory research
Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Or
Frequently Asked Questions
Who is eligible for Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)?
Eligibility includes new biomedical, behavioral, and social science investigators in early stages of establishing independent careers in tobacco regulatory research. Eligible applicant organizations include eligible federal agencies, faith-based or community-based organizations, Indian/Native American tribal governments, regional organizations, and U.S. territories or possessions. Non-domestic (non-U.S.) entities and foreign organizations are not eligible. For complete and current eligibility requirements, consult the official NIH/FDA funding announcement.
How much funding does Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) provide?
Awards under this program range from up to $75,000. The specific funding amount for individual awards may vary based on the scope and nature of proposed research. Applicants should refer to the official NOFO (Notice of Funding Opportunity) for current budget parameters and any annual adjustments.
How do I apply for Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)?
Applications are submitted through the NIH grants system. The next deadline is July 14, 2026. Applicants should prepare a complete research proposal addressing FDA CTP high-priority research topics, detailed budget justification, and organizational documentation. Visit the official NIH/FDA CTP website for detailed submission instructions, application forms, and technical assistance resources before applying.
What can Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) funding be used for?
Funding supports pilot and feasibility studies, secondary analysis of existing data, small self-contained research projects, research methodology development, and new research technology development. All projects must address high-priority research topics relevant to FDA's regulatory authority over tobacco product manufacturing, distribution, and marketing. Research should ultimately generate findings and data directly informing FDA tobacco product regulations and public health protection efforts.
Last updated: July 5, 2026